GlassScriptPhysician profile
Shahrooz Bemanian
NPI 1629123070
$10,158.09
in general payments reported to CMS, 2019-2025
34 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,590 · 2020: $565 · 2021: $1,027 · 2022: $1,607 · 2023: $2,086 · 2024: $1,954 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,368.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,433.03 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Janssen Biotech, INC. | $991.50 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $889.72 | 2019-2025 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $401.79 | 2019-2024 | Xifaxan |
| Regeneron Healthcare Solutions, INC. | $375.58 | 2022-2025 | Dupixent |
| Genzyme Corporation | $322.00 | 2022-2025 | |
| Gilead Sciences, INC. | $193.63 | 2019-2024 | |
| Boston Scientific Corporation | $166.05 | 2019-2024 | |
| Medtronic USA, INC. | $138.90 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $132.97 | 2023 | Zeposia |
| Covidien LP | $123.25 | 2019 | |
| Allergan, INC. | $112.56 | 2019-2020 | |
| Celgene Corporation | $97.11 | 2023-2024 | Zeposia |
| Lilly USA, LLC | $80.67 | 2023-2024 | Omvoh |
| Daiichi Sankyo INC. | $64.70 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $64.43 | 2020 | |
| Shionogi INC | $63.68 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $62.50 | 2023 | Eyemax |
| Intercept Pharmaceuticals, INC. | $56.62 | 2019 | |
| Ironwood Pharmaceuticals, INC | $40.47 | 2019-2022 | |
| Alfasigma USA, INC. | $39.37 | 2020-2021 | |
| Braintree Laboratories, INC. | $38.32 | 2019-2023 | Sutab |
| Redhill Biopharma INC. | $36.83 | 2021 | |
| Medtronic, INC. | $34.63 | 2022-2024 | Pillcam |
| Fisher & Paykel Healthcare INC | $33.67 | 2025 | Fisher & Paykel Healthcare |
| Ferring Pharmaceuticals INC. | $32.11 | 2019-2022 | |
| Celltrion USA INC. | $30.43 | 2024-2025 | Vegzelma, Zymfentra |
| Concordia Pharmaceuticals INC. | $17.98 | 2019 | |
| Dova Pharmaceuticals | $16.09 | 2019 | |
| Endogastric Solutions, INC | $15.26 | 2019 | |
| Pfizer INC. | $14.65 | 2019 | |
| Merck Sharp & Dohme LLC | $13.34 | 2020 | |
| Mallinckrodt Hospital Products INC. | $12.50 | 2022 | |
| Pentax of America, INC. | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahrooz Bemanian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.